Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$605M |
| 2 |
American Tower
AMT
|
+$352M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$347M |
| 4 |
TJX Companies
TJX
|
+$309M |
| 5 |
ExxonMobil
XOM
|
+$286M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 Growth ETF
IWF
|
+$924M |
| 2 |
Vanguard Russell 1000 Growth ETF
VONG
|
+$617M |
| 3 |
United Parcel Service
UPS
|
+$546M |
| 4 |
Qualcomm
QCOM
|
+$540M |
| 5 |
Eaton
ETN
|
+$469M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.22% |
| 2 | Financials | 10.48% |
| 3 | Healthcare | 9.58% |
| 4 | Industrials | 8.27% |
| 5 | Consumer Discretionary | 7.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Williams Companies
WMB
$86.1B
| $395M | 0.11% |
9,287,769
-361,600
| -4% | -$14.5M |
|
202
Regeneron Pharmaceuticals
REGN
$80.8B
| $395M | 0.11% |
374,878
+42,333
| +13% | +$41M |
|
203
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
$9.39B
| $393M | 0.11% |
9,478,693
+1,050,175
| +12% | +$43.2M |
|
204
BioMarin Pharmaceuticals
BMRN
$12.4B
| $387M | 0.1% |
4,701,326
-702,219
| -13% | -$58.5M |
|
205
Vanguard High Dividend Yield ETF
VYM
$83.5B
| $386M | 0.1% |
3,254,076
+27,123
| +0.8% | +$3.22M |
|
206
TechnipFMC
FTI
$27.3B
| $383M | 0.1% |
14,656,625
+569,818
| +4% | +$14.7M |
|
207
AstraZeneca
AZN
$250B
| $382M | 0.1% |
2,443,052
+17,656
| +0.7% | +$2.66M |
|
208
Boeing
BA
$185B
| $382M | 0.1% |
2,096,403
+1,036,543
| +98% | +$185M |
|
209
FirstEnergy
FE
$27.5B
| $380M | 0.1% |
9,941,242
-150,743
| -1% | -$5.85M |
|
210
DexCom
DXCM
$32B
| $378M | 0.1% |
3,332,318
-554,456
| -14% | -$70.1M |
|
211
CSX Corp
CSX
$93.1B
| $376M | 0.1% |
11,239,739
+3,168,172
| +39% | +$108M |
|
212
AES
AES
$10.5B
| $375M | 0.1% |
21,349,476
+482,566
| +2% | +$9.18M |
|
213
State Street Industrial Select Sector SPDR ETF
XLI
$34.6B
| $375M | 0.1% |
3,078,130
+644,817
| +26% | +$79.5M |
|
214
iShares MSCI Emerging Markets ex China ETF
EMXC
$24B
| $372M | 0.1% |
6,286,069
+1,062,286
| +20% | +$61.2M |
|
215
Goldman Sachs
GS
$303B
| $372M | 0.1% |
821,321
-97,102
| -11% | -$42.6M |
|
216
Newmont
NEM
$119B
| $369M | 0.1% |
8,815,886
+957,167
| +12% | +$39.1M |
|
217
AvalonBay Communities
AVB
$26.8B
| $368M | 0.1% |
1,778,684
-54,501
| -3% | -$10.5M |
|
218
Public Storage
PSA
$61.3B
| $366M | 0.1% |
1,272,650
-21,595
| -2% | -$5.95M |
|
219
Ecolab
ECL
$79.9B
| $366M | 0.1% |
1,531,926
-67,142
| -4% | -$15.5M |
|
220
Blackstone
BX
$110B
| $362M | 0.1% |
2,925,360
-68,292
| -2% | -$8.4M |
|
221
iShares Russell Mid-Cap ETF
IWR
$57.5B
| $360M | 0.1% |
4,442,809
-134,016
| -3% | -$10.9M |
|
222
F5
FFIV
$22.7B
| $359M | 0.1% |
2,086,174
+548,664
| +36% | +$95.9M |
|
223
Natera
NTRA
$46.4B
| $359M | 0.1% |
3,312,966
-128,964
| -4% | -$13.1M |
|
224
Aon
AON
$76B
| $358M | 0.1% |
1,218,558
+514,583
| +73% | +$152M |
|
225
O'Reilly Automotive
ORLY
$76.3B
| $355M | 0.1% |
5,038,605
-240,015
| -5% | -$16.6M |
|
Similar funds
Ameriprise's Q2 2024 Portfolio in Review
As of Q2 2024, Ameriprise held 3,986 positions worth $370B, up 1.7% from $363B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Ameriprise's Q2 2024 filing shows 147 new, 1,504 increased, 2,054 reduced and 132 closed positions. Its largest new stake was GE Vernova: 483,715 shares worth $83M. The largest sale was iShares Russell 1000 Growth ETF, an estimated $924M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
- Ameriprise's largest Q2 2024 buy was GE Vernova: 483,715 shares worth $83M.
- Ameriprise added most to Apple in Q2 2024, an estimated $605M increase.
- Ameriprise's biggest Q2 2024 reduction was iShares Russell 1000 Growth ETF, cutting an estimated $924M.
- Ameriprise fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $313M.
- Ameriprise's ten largest holdings make up 20% of its $370B portfolio in Q2 2024.
- Ameriprise opened 147 new positions and closed 132 in Q2 2024.
- Ameriprise's portfolio value rose 1.7% quarter-over-quarter to $370B.
Based on Ameriprise's 13F filing for Q2 2024, filed 14 Aug 2024.